Skip to main content

Table 2 Clinicopathological characteristics of patients treated with 3DCRT and IMRT

From: Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters

 

3DCRT (n = 32)

IMRT (n = 30)

 
 

Median

Range

Median

Range

p

Age (y)

47

31-70

44

24-65

N.S.

BMI (kg/m2)

20.8

14.2-27.7

21.2

15.7-32.5

N.S.

Total nedaplatin (mg)

290

120-350

283

56-420

N.S.

 

n

%

n

%

 

Smoker

8

25

12

40

N.S.

T-stage

T1

18

56

24

80

0.046

T2

14

44

6

20

N-stage

N0

22

69

24

80

N.S.

N1

10

31

6

20

Histology

SCC

23

72

16

53

N.S.

non-SCC

9

28

14

47

DSI

31

97

29

97

N.S.

LVI

13

41

9

30

N.S.

  1. 3DCRT three-dimensional conformal radiation therapy, IMRT intensity- modulated radiation therapy, BMI body mass inex, SCC squamous cell carcinoma, DSI deep stromal invasion, LVI lymphovascular invasion